Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast

Japanese Journal of Cancer Research

Volumn 91, Issue 11, 2000, Pages 1169-1176

  Ariga, Naohiro ^a   Moriya, Takuya ^a   Suzuki, Takashi ^a   Kimura, Michio ^b   Ohuchi, Noriaki ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KKR Tohoku Kousai Hospital   (Japan)

Author keywords

DCIS; Human breast; Proliferative disease; RAR; RXR

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CLASSIFICATION; CANCER TISSUE; CARCINOMA IN SITU; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; LABELING INDEX; MYOEPITHELIUM CELL; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; TUMOR CELL;

ADULT; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; MUTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033639286     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00901.x     Document Type: Article

References (42)

1. Can dietary beta-carotene materially reduce human cancer rates?
2. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
3. Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
4. Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: A comparison of the retinobenzoic acid derivative RE80 with retinoic acid
5. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro
6. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids
7. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression
8. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
9. Acute promyelocytic leukemia: From treatment to genetics and back
10. A human retinoic acid receptor which belongs to the family of nuclear receptors
11. Identification of a receptor for the morphogen retinoic acid
12. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
13. Identification of a second human retinoic acid receptor
14. A third human retinoic acid receptor, hRAR-γ
15. H-2R II BP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element
16. Nuclear receptor that identifies a novel retinoic acid response pathway
17. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid
18. Multiplicity generates diversity in the retinoic acid signaling pathways
19. A decade of molecular biology of retinoic acid receptors
20. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines
21. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a M(r) 39,000 protein
22. Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished expression of functional retinoic acid receptors
23. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen
24. Immunohistochemical analysis of retinoic acid receptor-α in human breast tumors: Retinoic acid receptor-α expression correlates with proliferative activity
25. Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis
26. Adjuvant treatment of stage I lung cancer with high-dose vitamin A
27. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids
28. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor
29. Estradiol induction of retinoic acid receptors in human breast cancer cells
30. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor α expression
31. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells
32. The correlation of Ki67 growth factor and ERICA in breast cancer
33. Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein
34. Ductal carcinoma in situ of the breast: Correlation between histologic classification and biologic markers
35. Risk factors for breast cancer in women with proliferative breast disease
36. Ductal carcinoma in situ of the female breast: Short-term results of a prospective nationwide study
37. Consensus conference on the classification of ductal carcinoma in situ
38. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland
39. p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
40. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
41. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements
42. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor γ, retinoid X receptor α, and all-trans retinoic acid than myometrium